DRUG RECALL

Pain Meds, Antibiotics Recalled

October 6, 2016

The US Food and Drug Administration (FDA) reported that a compounding pharmacy is recalling pain meds, antibiotics, and more.

What prompted the Class II recall? Pharmacy Plus could not assure the sterility of its products.

The following products were recalled: moxifloxacin HCI, morphine sulfate, methylcobalamin, autologous serum tears, papverine, among others.

__________________________________________________________________________________________________________________________________________________________________________

RELATED CONTENT
FDA Announces Talon Compounding Pharmacy Recall
Antibiotic Recalled Due to Iron Oxide Particulates

__________________________________________________________________________________________________________________________________________________________________________

The products were distributed in Mississippi.

In September, Wells Pharmacy Network launched a recall of all human and animal products manufactured in a particular date range due to a lack of assurance of sterility.

 

--Stephanie Vaccaro

 

Reference:

US Food and Drug Administration. FDA Enforcement Report – Week of October 5, 2016. www.fda.gov. Accessed October 6, 2016.